The "Silent Giant": Why Stellar (XLM) Just Became the Most Important Play of Q4

​While the market has been fixated on XRP's institutional inflows last week, its "sister chain" just executed one of the most significant upgrades in crypto history—and almost nobody noticed.

​If you are holding Stellar (XLM), or trading it on Futures, pay attention. The game just changed on November 24.

​The Upgrade That Changes Everything: Protocol X-Ray

​On November 24, 2025, the Stellar network successfully deployed Protocol X-Ray. This isn't just a catchy name; it marks the native integration of Zero-Knowledge (ZK) Proofs directly into the Stellar Core.

​Why does this matter?

For years, institutions loved Stellar's speed but feared its transparency. Banks cannot broadcast their entire ledger to the public. With Protocol X-Ray, Stellar now offers privacy-compliant smart contracts. It allows institutions to verify transactions without revealing sensitive data.

​This was the missing piece of the puzzle for the Soroban smart contract platform, which has already seen massive developer adoption throughout 2025.

​The "Sleepy" Price Action

​While XRP is dominating the headlines, XLM has been quietly consolidating around $0.40 - $0.42.

​The Setup: Technical indicators are flashing a "coiled spring" pattern.

​The Target: With the tech now live and flawless, analysts are eyeing a breakout to the $0.90 - $1.00 range by year-end 2025.

​The Human Angle

​Stellar has always been the "good guy" of crypto—focused on the unbanked, humanitarian aid, and cross-border utility. But "good" doesn't always pump bags.

Now, Stellar is no longer just "good"; it is dangerous to its competitors. It combines the speed of a payment layer with the privacy of a privacy coin and the smart contracts of Ethereum.

​The Takeaway:

XRP is the banker's handshake. XLM is the banker's vault. As the market digests the news of Protocol X-Ray, the "Silent Giant" might not stay silent for much longer.

​Disclaimer: This is not financial advice. Future trading carries high risk. DYOR.